image
Healthcare - Biotechnology - NASDAQ - US
$ 189.23
-2.1 %
$ 21 B
Market Cap
-23.08
P/E
INCOME STATEMENT
2.46 B REVENUE
73.65%
-1.21 B OPERATING INCOME
32.52%
-882 M NET INCOME
56.00%
EFFICIENCY
Earnings Waterfall BeiGene, Ltd.
image
Revenue 2.46 B
Cost Of Revenue 380 M
Gross Profit 2.08 B
Operating Expenses 3.29 B
Operating Income -1.21 B
Other Expenses -326 M
Net Income -882 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013
REVENUE
Revenue 2 458.8 1 415.9 1 176.3 308.9 428.2 198.2 238.4 1.1 8.8 13.0 11.1
GROSS PROFIT
Cost Of Revenue 379.9 1 927.0 1 624.1 1 365.5 998.5 707.7 274.0 98.0 58.2 21.9 13.5
Gross Profit 2 078.9 (511.1) (447.9) (1 056.7) (570.3) (509.5) (35.6) (97.0) (49.4) (8.8) (2.3)
OPERATING INCOME
Operating Expenses 3 286.6 1 278.6 990.9 601.0 389.6 196.3 62.9 20.1 7.3 6.9 3.1
Selling, General and Administrative Expenses 1 504.5 1 277.9 990.1 600.2 388.2 195.4 62.6 20.1 7.3 6.9 3.1
Research and Development Expenses 1 778.6 1 640.5 1 459.2 1 294.9 927.3 679.0 269.0 98.0 58 250.0 21.9 13.5
Operating Income (1 207.7) (1 789.7) (1 438.7) (1 657.7) (959.9) (705.8) (98.5) (117.1) (56.7) (15.8) (5.5)
PRE-TAX INCOME
Interest Income Expense 0 52.5 0 0.3 9.1 13.9 4.1 0.4 1.2 3.6 3.2
Total Other Income 381.9 (171.4) 0.1 39.5 16.3 15.9 7.4 (2.1) (0.4) (2.8) (2.4)
Pre-Tax Income (825.8) (1 961.0) (1 438.6) (1 618.2) (943.6) (689.8) (91.1) (119.2) (57.1) (18.5) (7.9)
NET INCOME
Tax Provision 55.9 42.8 (25.2) (17.7) 7.0 (15.8) 2.2 54 K 0.9 0.8 0.7
Net Income (881.7) (2 003.8) (1 413.4) (1 600.5) (950.6) (673.8) (93.1) (119.2) (57.1) (18.3) (7.5)
EPS 8.45 19.4 15.2 19.2 15.8 12.2 2.04 3 1.81 0.35 0.14